Related Experiment Videos
Type-C virus-like particles in a human B-cell lymphoma cell line
I Kubonishi1, Y Ohtsuki, T Sawada
1Department of Medicine, Kochi Medical School, Japan.
American Journal of Hematology
|September 1, 1990
Summary
Type-C virus-like particles (VLPs) were detected in Epstein-Barr virus-infected lymphoma cells. These particles were also found in new cell lines derived from these infected cells, suggesting a potential link in B-cell malignancies.
Area of Science:
- Virology
- Oncology
- Cell Biology
Background:
- Epstein-Barr virus (EBV) is associated with various B-cell malignancies.
- Human B-cell lymphoma cell lines can harbor and produce viral particles.
- Understanding viral co-infections or endogenous viral elements in cancer is crucial.
Purpose of the Study:
- To investigate the presence and characteristics of virus-like particles in an EBV-infected human B-cell lymphoma cell line.
- To determine if these particles are present in newly established cell lines derived from the infected line.
Main Methods:
- Establishment and characterization of a human B-cell lymphoma cell line (SP-50B) from a non-Hodgkin lymphoma patient.
- Electron microscopy to visualize and measure virus-like particles (VLPs).
- Coculture of irradiated SP-50B cells with human cord blood and chronic lymphocytic leukemia (CLL) cells to establish new cell lines.
- Antigen and genome detection for Human T-lymphotropic virus (HTLV-I/II).
Main Results:
- Type-C virus-like particles (VLPs), 150-200 nm in diameter, were continuously produced by the SP-50B cell line for over a year.
- SP-50B cells tested negative for HTLV-I and HTLV-II antigens and genome.
- Identical type-C VLPs were observed in two new EBV nuclear antigen (EBNA)-positive B-cell lines (SP-54-Cord and SP-57-CLL) derived from SP-50B cells.
Conclusions:
- The SP-50B cell line persistently produces type-C VLPs.
- These type-C VLPs are transferable or associated with EBV-infected B-cells and can be found in newly derived cell lines.
- The findings suggest an association between EBV infection, B-cell lymphoma, and the production of type-C VLPs.